The Quantum Light Switch Hidden Inside Every Protein
Proteins are often described as the body’s molecular machines, but the metaphor has always been missing something: an off switch. When a protein misfires, there is no handy dial you can turn to dial its activity back down. For decades, the dream of controlling individual proteins with the precision of a light switch — quite literally, using light — has been one of the holy grails of biochemistry. Now, a team of researchers at the Weizmann Institute of Science in Israel and Caltech has achieved exactly that. And the mechanism they uncovered is so strange that it belongs as much to quantum physics as it does to biology.
Background & Context
The idea that electric fields matter inside cells is not new. Every biology student learns about the voltage difference across cell membranes — the same electrical potential that makes neurons fire and heart muscles contract. What has remained almost entirely unexplored is whether these same electric fields can reach inside individual proteins and change what they do. After all, proteins are not passive blobs. They have intricate three-dimensional shapes, charged amino acid residues, and internal electric fields of their own. The question is whether those internal fields can be rearranged — and whether that rearrangement, by itself, can alter function.
There has been tantalising evidence. Simulations by the Takano group in Japan suggested that charges moving inside a protein could act as a kind of “dielectric allostery” — a control signal transmitted not through a shape change, as in classical allostery, but through pure charge redistribution. Earlier experimental work from the same Weizmann team had shown that simply placing a protein on a gold surface versus glass could modulate how it binds to its partners, hinting that electric fields at the protein’s feet ripple upward and affect distant binding sites. But no one had directly demonstrated that sending a charge through a protein could turn its activity up or down on demand. Until now.
What the Researchers Did
The team, led by Gilad Haran and Ron Naaman at Weizmann together with Harry Gray at Caltech, chose a workhorse protein called phosphoglycerate kinase — PGK for short. It is a 415-residue enzyme that helps cells break down sugar, transferring a phosphate group from ATP to another molecule. Into this protein, at carefully chosen locations, they stitched a tiny molecular antenna: a ruthenium-based photosensitizer, essentially a dye that absorbs blue light and, when excited, can inject an electron (or a positively charged “hole”) into the surrounding protein. Think of it as wiring a solar panel directly into the protein’s internal circuitry.
They placed this antenna at two different positions. Position 9, near the C-terminus where the protein’s histidine tag sits — close to the region that antibodies recognise. And position 290, near the active site where the enzyme does its catalytic work. Then they asked two simple questions. First: if we shine light on this protein, does it change how well it binds to an antibody? Second: does it change how fast the enzyme works? To answer these questions, they tethered the proteins to a surface — either gold or glass — bathed them in either the antibody solution or a cocktail of substrates, and hit them with a 470-nanometer laser.
What makes the experiment truly elegant is the control they built in. They tested the same protein without the ruthenium antenna attached. No antenna, no effect — ruling out the possibility that the light was simply heating up the solution or causing some other non-specific disturbance. They also varied the polarisation of the light: linearly polarised, left circularly polarised, and right circularly polarised. This is where the story takes a quantum turn.
What They Found
The results were striking. When the ruthenium antenna sat at position 9 and the laser was on, antibody binding to the protein increased by a factor of 2.25 at the two-second mark. The protein became more than twice as sticky to its binding partner, purely because charge had been injected into it. When they moved the antenna to position 290, far from the antibody binding site, the effect vanished — confirming that the charge reorganization signal does not travel indefinitely. It matters where you inject it.
Then came the enzyme kinetics experiment — and the results were even more dramatic. With the antenna at position 290, near the active site, illumination caused the enzyme’s turnover rate to plummet by a factor of 3.3. The same protein, under the same conditions, processed substrate three times slower when the light was on. They could watch this effect in real time: turn the laser on, and the slope of the reaction curve would drop. Turn it off, and the enzyme would speed back up. Reversibly. Repeatably. When the antenna was moved to position 9, the effect was still present but halved — a 1.8-fold reduction instead of 3.3.
But the result that will make quantum physicists sit up in their chairs concerns the polarisation. Only left circularly polarised light produced these effects. Right circularly polarised light did nothing. In a classical world, this makes no sense — left and right circular polarisation are mirror images of each other, identical in energy and intensity. The fact that the protein discriminates between them means that the charge moving through it must be spin-polarised. The electrons are not just moving; they are spinning in a specific direction, and the protein’s chiral architecture — its left-handed helices and asymmetric folds — acts as a spin filter, letting through one orientation while blocking the other.
Why It Matters
This paper is, in essence, the experimental birth certificate for a new category of biological control mechanism. For a century, the dominant model of protein regulation has been allostery: a molecule binds to one site on a protein, causing a shape change that affects a distant site. Hemoglobin and oxygen are the textbook example. But the Weizmann-Caltech team is proposing something different: a signal that travels not through mechanical deformation but through charge rearrangement. They call it charge-reorganization allostery. It is faster, subtler, and — crucially — it can be triggered externally, with light.
The implications for fundamental biology are profound. Cells are awash in electric fields, particularly near membranes where voltage differences can reach tens of millivolts across just a few nanometres. If charge reorganization can modulate enzyme activity by a factor of three, then the bioelectric environment inside a cell is not mere background noise — it may be actively tuning the function of individual proteins from moment to moment. The finding also resolves a long-standing puzzle in the chiral-induced spin selectivity (CISS) effect, a phenomenon discovered by Ron Naaman’s group in which electron transport through chiral molecules — including proteins — becomes spin-selective. Critics have wondered whether CISS has any biological relevance. This paper slams the door on that doubt. Spin selectivity is not just a laboratory curiosity; it is a switch the cell can use.
How It Could Change Our Lives
Let’s get concrete. Imagine a drug that is inactive in the dark but becomes active when you shine a specific colour of light on the right part of the body. No more systemic side effects from chemotherapy agents that poison every dividing cell in your body — instead, a photoswitchable enzyme inhibitor that you activate only at the tumour site with a fibre-optic probe. This is not science fiction. The technique demonstrated here — attaching a ruthenium photosensitizer to a specific location on a protein — is generalisable. Any protein with a cysteine residue at a known position could, in principle, be light-controlled.
There are nearer-term possibilities too. The biosensor industry, currently valued at over $25 billion, depends on proteins that change their behaviour when they encounter a target molecule. What if you could build a sensor that changes its behaviour when you flash a light at it instead — or in addition? Rapid, reversible, optical control of protein function could transform everything from industrial enzyme reactors to point-of-care diagnostics. A factory that produces biofuels could tune its enzyme cascade with LEDs. A medical device could use light pulses to control the rate of an enzymatic reaction. The ruthenium dye used here absorbs at 470 nanometres — visible blue light, safe for biological tissue — making it immediately compatible with existing optical instrumentation.
The Bigger Picture
This work sits at a fascinating crossroads between three fields that rarely share a conference room: quantum physics, structural biology, and bioelectronics. The discovery that the chiral-induced spin selectivity effect operates inside a functioning enzyme — and can change its activity — elevates CISS from a curiosity of condensed-matter physics to a phenomenon with demonstrable biological function. It also reinforces a growing recognition that biology is not a purely classical enterprise. From magnetoreception in migratory birds to the efficiency of photosynthesis, quantum effects keep showing up in living systems. The spin-polarised control of enzyme activity is a new entry on that list — and it may be one of the most practically useful.
Limitations & What’s Next
The researchers are refreshingly candid about what they cannot yet explain. They do not know whether the injected charge is an electron or a hole. They cannot trace the exact path the charge takes through the protein’s interior, or say which secondary structures — alpha helices, beta sheets, loops — do the actual spin-filtering work. The effect is position-dependent, but the relationship between distance, protein structure, and the strength of the effect is not yet mapped. And the experiments were performed on proteins immobilised on surfaces, not floating freely in solution as they would be inside a cell.
What comes next is both a mapping exercise and an engineering challenge. The team plans to identify biological systems that are particularly susceptible to charge-reorganization control — membrane proteins, perhaps, which already sit in strong electric fields. They also want to optimise photosensitizer placement to maximise the effect, and to trace the charge-rearrangement pathways more precisely using time-resolved spectroscopy. If they succeed, we may one day look back on this paper as the moment when light became a universal remote control for the molecular machines that run our bodies.
📄 Source: Ghosh, S., Banerjee-Ghosh, K., Levy, D., Scheerer, D., Riven, I., Shin, J., Gray, H.B., Naaman, R., & Haran, G. (2026). Control of protein activity by photoinduced spin polarized charge reorganization. arXiv:2606.01662v1. Weizmann Institute of Science & California Institute of Technology.